Washington, Nov 8: After successfully conducting studies on mice, scientists have claimed that SRT1720, touted as an "anti-aging pill,” can be tested in human trials.
The new drug study from Sirtris Pharmaceuticals, Inc., based in Cambridge, Mass., claimed that SRT1720 activates the same receptor as the much-discussed resveratrol, the chemical in red wine that may slow some effects of aging.
Scientists are testing both resveratrol and SRT1720 for first treating type-two diabetes, and possibly later for other age-related diseases.